AE Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $71.6M | Buy |
329,432
+35,412
| +12% | +$7.86M | 0.39% | 62 |
|
|
2025
Q4 | $67.2M | Buy |
294,020
+7,696
| +3% | +$1.75M | 0.39% | 63 |
|
|
2025
Q3 | $66.3M | Buy |
286,324
+18,651
| +7% | +$3.8M | 0.42% | 54 |
|
|
2025
Q2 | $49.7M | Buy |
267,673
+17,167
| +7% | +$3.19M | 0.36% | 66 |
|
|
2025
Q1 | $52.5M | Buy |
250,506
+6,786
| +3% | +$1.32M | 0.44% | 53 |
|
|
2024
Q4 | $43.3M | Buy |
243,720
+17,791
| +8% | +$3.27M | 0.37% | 63 |
|
|
2024
Q3 | $44.6M | Sell |
225,929
-29,742
| -12% | -$5.55M | 0.4% | 55 |
|
|
2024
Q2 | $43.9M | Buy |
255,671
+53,590
| +27% | +$8.88M | 0.44% | 52 |
|
|
2024
Q1 | $36.8M | Sell |
202,081
-129,442
| -39% | -$22.3M | 0.42% | 57 |
|
|
2023
Q4 | $54.5M | Buy |
331,523
+4,532
| +1% | +$661K | 0.28% | 72 |
|
|
2023
Q3 | $48.7M | Buy |
326,991
+19,986
| +7% | +$2.93M | 0.29% | 64 |
|
|
2023
Q2 | $41.4M | Sell |
307,005
-7,704
| -2% | -$1.13M | 0.25% | 76 |
|
|
2023
Q1 | $50.2M | Sell |
314,709
-2,634
| -0.8% | -$403K | 0.32% | 52 |
|
|
2022
Q4 | $51.3M | Buy |
317,343
+12,699
| +4% | +$1.95M | 0.37% | 43 |
|
|
2022
Q3 | $40.9M | Buy |
304,644
+42,675
| +16% | +$6.12M | 0.32% | 59 |
|
|
2022
Q2 | $40.1M | Sell |
261,969
-17,757
| -6% | -$2.71M | 0.32% | 68 |
|
|
2022
Q1 | $45.3M | Sell |
279,726
-5,841
| -2% | -$848K | 0.31% | 64 |
|
|
2021
Q4 | $38.7M | Buy |
285,567
+41,265
| +17% | +$4.87M | 0.27% | 78 |
|
|
2021
Q3 | $26.4M | Buy |
244,302
+7,506
| +3% | +$858K | 0.22% | 105 |
|
|
2021
Q2 | $26.7M | Buy |
236,796
+27,943
| +13% | +$3.15M | 0.23% | 103 |
|
|
2021
Q1 | $22.6M | Buy |
208,853
+10,379
| +5% | +$1.11M | 0.23% | 102 |
|
|
2020
Q4 | $21.3M | Buy |
198,474
+14,258
| +8% | +$1.37M | 0.24% | 97 |
|
|
2020
Q3 | $16.1M | Sell |
184,216
-23,596
| -11% | -$2.22M | 0.23% | 100 |
|
|
2020
Q2 | $20.4M | Buy |
207,812
+59,028
| +40% | +$5.2M | 0.32% | 71 |
|
|
2020
Q1 | $11.3M | Buy |
148,784
+12,324
| +9% | +$1.05M | 0.26% | 78 |
|
|
2019
Q4 | $12.1M | Buy |
136,460
+31,730
| +30% | +$2.63M | 0.26% | 79 |
|
|
2019
Q3 | $7.93M | Buy |
104,730
+16,163
| +18% | +$1.11M | 0.23% | 83 |
|
|
2019
Q2 | $6.44M | Buy |
88,567
+50,072
| +130% | +$3.94M | 0.19% | 94 |
|
|
2019
Q1 | $3.1M | Buy |
38,495
+5,905
| +18% | +$483K | 0.22% | 94 |
|
|
2018
Q4 | $3M | Sell |
32,590
-6,501
| -17% | -$572K | 0.51% | 49 |
|
|
2018
Q3 | $3.7M | Buy |
39,091
+9,047
| +30% | +$858K | 0.2% | 86 |
|
|
2018
Q2 | $2.78M | Buy |
30,044
+7,592
| +34% | +$741K | 0.19% | 83 |
|
|
2018
Q1 | $2.13M | Sell |
22,452
-2,066
| -8% | -$227K | 0.16% | 91 |
|
|
2017
Q4 | $2.37M | Sell |
24,518
-12,396
| -34% | -$1.17M | 0.21% | 80 |
|
|
2017
Q3 | $3.28M | Sell |
36,914
-8,638
| -19% | -$658K | 0.3% | 57 |
|
|
2017
Q2 | $3.3M | Buy |
45,552
+4,466
| +11% | +$300K | 0.39% | 52 |
|
|
2017
Q1 | $2.68M | Buy |
41,086
+13,334
| +48% | +$838K | 0.5% | 41 |
|
|
2016
Q4 | $1.74M | Buy |
+27,752
| New | +$1.69M | 0.7% | 29 |
|
Other funds holding ABBV
VCM
VPM
AE Wealth Management's ABBV Position: Q1 2026 in Review
AE Wealth Management increased its AbbVie (ABBV) stake by 12% in Q1 2026, buying an estimated $7.86M and bringing the position to 329,432 shares worth $71.6M. The position accounts for 0.39% of the portfolio, ranked #62.
AE Wealth Management first reported a position in ABBV in Q4 2016 and has held it in 38 quarters since. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- AE Wealth Management held 329,432 shares of AbbVie worth $71.6M as of Q1 2026.
- AE Wealth Management bought 35,412 AbbVie shares in Q1 2026, an estimated $7.86M.
- AbbVie made up 0.39% of AE Wealth Management's portfolio in Q1 2026, its #62 holding.
- AE Wealth Management first reported a position in AbbVie in Q4 2016 and has held it in 38 quarters since.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on AE Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.